FALVELLA, FELICIA STEFANIA

FALVELLA, FELICIA STEFANIA  

Universita' degli Studi di MILANO  

Risultati 1 - 15 di 15 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Atazanavir-induced severe episodes of kidney stones in an HIV-1-infected subject characterized by a CYP3A poor metabolizer phenotype 15-nov-2014 S. RusconiF.S. FalvellaD. CattaneoV. Di CristoE. ClementiM. Galli + Article (author) -
A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID-19 severity 1-gen-2020 Elena AloisioMariia ChibirevaLudovica SerafiniFelicia S. FalvellaAlberto DolciMauro Panteghini + Article (author) -
Deferasirox-induced serious adverse reaction in a pediatric patient : pharmacokinetic and pharmacogenetic analysis 1-feb-2016 F. StoppaE. ClementiF.S. Falvella + Article (author) -
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 1-set-2015 F.S. FalvellaS. CheliC. MazzaliC. MaggiM. Di BartolomeoI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
HLA-B*57: 01 testing : Care in interpreting the quality of different genotyping methods 1-feb-2017 F.S. FalvellaS. CheliE. Clementi Article (author) -
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? 1-ott-2019 Nichetti, FedericoFalvella, Felicia StefaniaCheli, StefaniaFucà, GiovanniInfante, Gabrielede Braud, FilippoPietrantonio, Filippo + Article (author) -
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 1-mag-2021 Passerini, MatteoPiscaglia, MarcoMorena, ValentinaGiacomelli, AndreaFalvella, StefaniaCossu, Maria VittoriaCapetti, Amedeo F + Article (author) -
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors 1-gen-2015 A. LombardiS. CheliC. MazzaliE. ClementiF.S. Falvella + Article (author) -
Levofloxacin-induced seizures in a patient without predisposing risk factors : the impact of pharmacogenetics 1-ago-2013 D. CattaneoF.S. FalvellaP. VitielloS. CheliE. ClementiA. Riva + Article (author) -
Multiple Loci modulate opioid therapy response for cancer pain 1-gen-2011 Falvella FSCaraceni A + Article (author) -
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting 1-gen-2017 F.S. FalvellaD. CattaneoC. MazzaliRONZI, PAOLAF. BindaS. CheliS. Antinori + Article (author) -
The role of Toll-like receptor 4 polymorphisms in vaccine immune response 1-feb-2016 P. PellegrinoF.S. FalvellaS. CheliC. PerrottaE. ClementiS. Radice Article (author) -
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir 1-apr-2015 A.M. PeriC. MazzaliE. CalviE. ClementiS. CheliS. AntinoriF.S. Falvella + Article (author) -
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 1-gen-2015 F.S. FalvellaS. CheliC. MaggiM. NigerF. RicchiniI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
An unexpectedly prolonged severe hyperbilirubinemia in a patient with pre-existing hepatitis A: A role of genetic predisposition? 13-nov-2018 Falvella, Felicia StefaniaClementi, EmilioPanteghini, Mauro + Article (author) -